OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma

Marwan Ghosn,Roland Eid,Emad Hamada,Hamdy A. Azim,Jamal Zekri,Mubarak Al-Mansour,Mohammed Jaloudi,Fadi Nasr,Hassan Errihani,A. Bounedjar,Amel Mezlini,Hamouda Boussen,Joseph Kattan,Fadi El Karak,Fadi Farhat

OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma

2019

Marwan Ghosn
Roland Eid
Emad Hamada
Hamdy A. Azim
Jamal Zekri
Mubarak Al-Mansour
Mohammed Jaloudi
Fadi Nasr
Hassan Errihani
A. Bounedjar
Amel Mezlini
Hamouda Boussen
Joseph Kattan
Fadi El Karak
Fadi Farhat

PURPOSESunitinib offers improved efficacy for patients with metastatic renal cell carcinoma (mRCC). To provide better disease management in the Middle East, we studied its use in mRCC in real-life ...

Keywords:

Observational study
Oncology
Disease
Sunitinib
Renal cell carcinoma
Medicine
Internal medicine
disease management
in real life

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations